TY - JOUR
T1 - Factors affecting formula compliance of infants with IgE mediated cow's milk protein allergy during the pandemic
AU - Uygun, Dilara Kocacik
AU - Karaatmaca, Betul
AU - Topal, Erdem
AU - Arga, Mustafa
AU - Sancakli, Ozlem
AU - Ozcan, Dilek
AU - Igde, Mahir
AU - Cekic, Sukru
AU - Bingol, Gulbin
AU - Buyuktiryaki, Betul
AU - Sackesen, Cansin
AU - Sursal, Alihan
AU - Ozdener, Fatih
AU - Bingol, Aysen
N1 - Publisher Copyright:
2023 Uygun, Karaatmaca, Topal, Arga, Sancakli, Ozcan, Igde, Cekic, Bingol, Buyuktiryaki, Sackesen, Sursal, Ozdener and Bingol.
PY - 2023
Y1 - 2023
N2 - Introduction: Cow's milk protein allergy (CMPA) is the most commonly encountered food allergy in the world, usually seen in infants under the age of 2 years. This study aims to determine the factors including COVID-19 affecting formula compliance of CMPA patients. Methods: This study is a prospective, observational study based on 10 different Paediatric Allergy-Immunology clinics in Turkey. Patients aged between 6 months and 2 years, who were followed up with IgE-mediated CMPA treatment or newly diagnosed and using breast milk and/or formula were included in the study. The sociodemographic characteristics of the patients, their symptoms, the treatments they received, and the effects of the COVID-19 pandemic on adherence to formula were evaluated with a questionnaire administered to the parents. Results: The compliance rate for formula-based treatment was 30.8% (IQR: 28.3, SD: 21.86). The number of patients with a single and multiple food allergy was 127 (51.6%) and 71 (28.9%), respectively. Breastfeeding duration, daily amount of prescribed formula and addition of sweetener to the formula were found to reduce compliance (p = 0.010, p = 0.003, and p = 0.004, respectively). However, it was determined that the patient's height, weight, age at diagnosis, and age of formula onset did not have a significant effect on compliance. Conclusion: It was found that the duration of breastfeeding, the increase in the daily amount of formula requirement, and the addition of sweeteners had adverse effects on formula compliance. There was no significant correlation between the formula adherence of CMPA patients and the pandemic.
AB - Introduction: Cow's milk protein allergy (CMPA) is the most commonly encountered food allergy in the world, usually seen in infants under the age of 2 years. This study aims to determine the factors including COVID-19 affecting formula compliance of CMPA patients. Methods: This study is a prospective, observational study based on 10 different Paediatric Allergy-Immunology clinics in Turkey. Patients aged between 6 months and 2 years, who were followed up with IgE-mediated CMPA treatment or newly diagnosed and using breast milk and/or formula were included in the study. The sociodemographic characteristics of the patients, their symptoms, the treatments they received, and the effects of the COVID-19 pandemic on adherence to formula were evaluated with a questionnaire administered to the parents. Results: The compliance rate for formula-based treatment was 30.8% (IQR: 28.3, SD: 21.86). The number of patients with a single and multiple food allergy was 127 (51.6%) and 71 (28.9%), respectively. Breastfeeding duration, daily amount of prescribed formula and addition of sweetener to the formula were found to reduce compliance (p = 0.010, p = 0.003, and p = 0.004, respectively). However, it was determined that the patient's height, weight, age at diagnosis, and age of formula onset did not have a significant effect on compliance. Conclusion: It was found that the duration of breastfeeding, the increase in the daily amount of formula requirement, and the addition of sweeteners had adverse effects on formula compliance. There was no significant correlation between the formula adherence of CMPA patients and the pandemic.
KW - CMPA
KW - COVID-19 pandemic
KW - IgE mediated food allergy
KW - infants
KW - treatment adherence
UR - http://www.scopus.com/inward/record.url?scp=85159896352&partnerID=8YFLogxK
U2 - 10.3389/falgy.2023.1017155
DO - 10.3389/falgy.2023.1017155
M3 - Article
AN - SCOPUS:85159896352
SN - 2673-6101
VL - 4
JO - Frontiers in Allergy
JF - Frontiers in Allergy
M1 - 1017155
ER -